Latest Form 4 insider transactions

Lori Jean Robinson, a Director of Korn Ferry, received 2,780 shares of common stock on September 24, 2026.

Laura M Bishop, a Director of Korn Ferry, received 2,780 shares of common stock on September 24, 2026.

Peter A Shimer, a Director of Korn Ferry, received 2,780 shares of common stock on September 24, 2026.

Albert Miranda, CFO of Lightpath Technologies Inc, received 17,091 shares of common stock on August 18, 2026.

Matthew J Espe, a Director of Korn Ferry, received 2,780 shares of common stock on September 24, 2026.

Russell Hagey, a Director of Korn Ferry, received 4,100 shares of common stock on September 24, 2026.

Doyle N Beneby, a Director of Korn Ferry, received 2,780 shares of common stock on September 24, 2026.

Shmuel Rubin, President & CEO of Lightpath Technologies Inc, received 39,381 shares of common stock on August 18, 2026.

Kevin T Conroy, a Director of Abbott Laboratories, reported a transaction in 52,507 shares of common stock on September 23, 2026.

Angel R Martinez, a Director of Korn Ferry, received 2,780 shares of common stock on September 24, 2026.

Debra Lou Smith, Chief Financial Officer of CISO Global, Inc., reported multiple transactions in common stock on June 13, 2026.

Anselm Wong, CFO, EVP of Janus International Group, Inc., received 176,056 shares of common stock on September 23, 2026.

Norman Nettie V, EVP, Corporate Operations of Janus International Group, Inc., received 176,056 shares of common stock on September 23, 2026.

Morgan Hodges, Executive Vice President of Janus International Group, Inc., received 176,056 shares of common stock on September 23, 2026.

ENDRA Life Sciences Inc. has filed a Form 425 detailing proposed transactions with Renergen, Noble Africa, and ASP Isotopes, outlining potential benefits and significant risks.

Debra Lou Smith, Chief Financial Officer of CISO Global, Inc., reported multiple transactions in common stock on June 13, 2025.

AJB Investment Fund II, LP and 3 others reported changes in beneficial ownership of Jewett Cameron Trading Co Ltd common stock on September 23, 2026.

David Grant Jemmett, Chief Executive Officer and a Director of CISO Global, Inc., reported multiple transactions in common stock on June 13, 2026.

Thomas O Daniel, a Director of Gossamer Bio, Inc., received 10,000 shares of common stock on September 23, 2026.

Rodriguez Felix Matos V., a Director of Affiliated Managers Group, Inc., reported multiple transactions in common stock on August 15, 2026.

Gregory Austin Ciongoli, a Director of Gossamer Bio, Inc., received 30,000 shares of common stock on September 23, 2026.

Philip & Daniele Barach Family Trust reported changes in beneficial ownership of Celularity Inc common stock on September 23, 2026.

Daniele Wolf Barach, a 10% owner of Celularity Inc, reported multiple transactions in common stock on September 23, 2026.

Philip Alan Barach, a Director and 10% owner of Celularity Inc, reported multiple transactions in common stock on September 23, 2026.

Robert E Cauley, Chief Executive Officer and a Director of Orchid Island Capital, Inc., reported multiple transactions in common stock on September 25, 2026.

Skye Drynan, a Director of Gossamer Bio, Inc., received 10,000 shares of common stock on September 23, 2026.

Se Totalenergies and 4 others reported changes in beneficial ownership of TotalEnergies SE common stock on September 23, 2026.

Se Totalenergies and 4 others reported changes in beneficial ownership of Clearway Energy, Inc. common stock on September 23, 2026.

Timothy J. Cutt, a Director of Gulfport Energy Corp, sold 2,500 shares of common stock on September 24, 2026 for $158.98 per share.

G Hunter Haas Iv, Chief Financial Officer and a Director of Orchid Island Capital, Inc., reported multiple transactions in common stock on September 25, 2026.